Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ramzi M. Mohammad

Anti-Tumor Activity of Selective Inhibitor of Nuclear Export (SINE) Compounds, Is Enhanced in Non-Hodgkin Lymphoma Through Combination With mTOR Inhibitor and Dexamethasone

Cancer Letters

Cancer Research

Oncology

2016

English

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

PLoS ONE

Multidisciplinary

2012

English

Related publications

The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma

Cancer Discovery

Oncology

2017

English

Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models

Journal of Experimental and Clinical Cancer Research

Cancer Research

Oncology

2014

English

Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185

PLoS ONE

Multidisciplinary

2015

English

Pre-Clinical Pharmacology of AZD3965, a Selective Inhibitor of McT1: DLBCL, NHL and Burkitt’s Lymphoma Anti-Tumor Activity

Oncotarget

Oncology

2017

English

Selective Inhibitors of Nuclear Export (SINE)– A Novel Class of Anti-Cancer Agents

Journal of Hematology and Oncology

English

Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces RSV Replication in Vitro

English

Combination Treatment With Doxorubicin and microRNA-21 Inhibitor Synergistically Augments Anticancer Activity Through Upregulation of Tumor Suppressing Genes

International Journal of Oncology

Cancer Research

Oncology

2015

English

Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

PLoS ONE

Multidisciplinary

2014

English

The Dual PI3K/mTOR Inhibitor, NVP-BEZ235, Is Efficacious Against Follicular Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ramzi M. Mohammad

Anti-Tumor Activity of Selective Inhibitor of Nuclear Export (SINE) Compounds, Is Enhanced in Non-Hodgkin Lymphoma Through Combination With mTOR Inhibitor and Dexamethasone

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

Related publications

The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma

Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models

Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185

Pre-Clinical Pharmacology of AZD3965, a Selective Inhibitor of McT1: DLBCL, NHL and Burkitt’s Lymphoma Anti-Tumor Activity

Selective Inhibitors of Nuclear Export (SINE)– A Novel Class of Anti-Cancer Agents

Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces RSV Replication in Vitro

Combination Treatment With Doxorubicin and microRNA-21 Inhibitor Synergistically Augments Anticancer Activity Through Upregulation of Tumor Suppressing Genes

Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

The Dual PI3K/mTOR Inhibitor, NVP-BEZ235, Is Efficacious Against Follicular Lymphoma